Discover the emerging field of AI-based peptide discovery and design – could this signal the beginning of a golden age for ...
Discover five promising Prader-Willi syndrome therapies climbing the clinical ladder and nearing FDA approval in the coming ...
Home to a well-established hub with strong investment and startup activity, discover what makes Cambridge's biotech scene so ...
BIOSPAIN showed how partnering conferences connect public funding, venture capital, and pharma to drive biotech innovation to ...
The U.K. has had a stronghold on the biopharma and healthcare industry for a long time and remains one of the top hubs for ...
Discover the top biotech deals of September 2025, as four billion-dollar acquisitions took place and several licensing deals ...
Discover how AKIGAI’s EGFR inhibitors may redefine neuropathic pain therapy and offer hope for complex regional pain syndrome ...
Qure, Dianthus Therapeutics, and Mineralys Therapeutics bagged the biggest biotech funding rounds overall in September 2025.
The Asabys-Aliath integration signals how European biotech VCs are scaling and adapting amid funding pressures.
In 2020, Novo Nordisk’s Canadian patent for semaglutide, the active ingredient in its blockbuster GLP-1 drugs Ozempic and Wegovy, quietly expired. The reason? A small missed maintenance fee, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback